Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes

Abstract Xanthine oxidoreductase (XOR) catalyzes the oxidation of hypoxanthine to xanthine, and of xanthine to uric acid. XOR also enhances the production of reactive oxygen species and causes endothelial dysfunction. In this study, we evaluated the association of XOR and its substrate with the vasc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tomoko Okuyama, Jun Shirakawa, Takashi Nakamura, Takayo Murase, Daisuke Miyashita, Ryota Inoue, Mayu Kyohara, Yu Togashi, Yasuo Terauchi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/87d7f33d032f4a0a800350751de49494
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:87d7f33d032f4a0a800350751de49494
record_format dspace
spelling oai:doaj.org-article:87d7f33d032f4a0a800350751de494942021-12-02T14:26:55ZAssociation of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes10.1038/s41598-021-83234-92045-2322https://doaj.org/article/87d7f33d032f4a0a800350751de494942021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83234-9https://doaj.org/toc/2045-2322Abstract Xanthine oxidoreductase (XOR) catalyzes the oxidation of hypoxanthine to xanthine, and of xanthine to uric acid. XOR also enhances the production of reactive oxygen species and causes endothelial dysfunction. In this study, we evaluated the association of XOR and its substrate with the vascular complications in 94 Japanese inpatients with type 2 diabetes (T2DM). The plasma XOR activity and plasma xanthine levels were positively correlated with the body mass index, aspartate aminotransferase (AST), alanine aminotransferase (ALT), γ-GTP, fasting plasma insulin, and the homeostasis model of assessment of insulin resistance (HOMA-IR), and negatively correlated with the high density lipoprotein cholesterol. The plasma XOR activity also showed a positive correlation with the serum triglyceride. Multivariate analyses identified AST, ALT, fasting plasma insulin and HOMA-IR as being independently associated with the plasma XOR activity. The plasma XOR activity negatively correlated with the duration of diabetes, and positively correlated with the coefficient of variation of the R-R interval and sensory nerve conduction velocity. Furthermore, the plasma XOR activity was significantly decreased in patients with coronary artery disease. Thus, the plasma XOR activity might be a surrogate marker for the development of vascular complications, as well as liver dysfunction and insulin resistance, in T2DM. Trial registration: This study is registered at the UMIN Clinical Trials Registry (UMIN000029970; https://www.umin.ac.jp/ctr/index-j.htm ). The study was conducted from Nov 15, 2017.Tomoko OkuyamaJun ShirakawaTakashi NakamuraTakayo MuraseDaisuke MiyashitaRyota InoueMayu KyoharaYu TogashiYasuo TerauchiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Tomoko Okuyama
Jun Shirakawa
Takashi Nakamura
Takayo Murase
Daisuke Miyashita
Ryota Inoue
Mayu Kyohara
Yu Togashi
Yasuo Terauchi
Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes
description Abstract Xanthine oxidoreductase (XOR) catalyzes the oxidation of hypoxanthine to xanthine, and of xanthine to uric acid. XOR also enhances the production of reactive oxygen species and causes endothelial dysfunction. In this study, we evaluated the association of XOR and its substrate with the vascular complications in 94 Japanese inpatients with type 2 diabetes (T2DM). The plasma XOR activity and plasma xanthine levels were positively correlated with the body mass index, aspartate aminotransferase (AST), alanine aminotransferase (ALT), γ-GTP, fasting plasma insulin, and the homeostasis model of assessment of insulin resistance (HOMA-IR), and negatively correlated with the high density lipoprotein cholesterol. The plasma XOR activity also showed a positive correlation with the serum triglyceride. Multivariate analyses identified AST, ALT, fasting plasma insulin and HOMA-IR as being independently associated with the plasma XOR activity. The plasma XOR activity negatively correlated with the duration of diabetes, and positively correlated with the coefficient of variation of the R-R interval and sensory nerve conduction velocity. Furthermore, the plasma XOR activity was significantly decreased in patients with coronary artery disease. Thus, the plasma XOR activity might be a surrogate marker for the development of vascular complications, as well as liver dysfunction and insulin resistance, in T2DM. Trial registration: This study is registered at the UMIN Clinical Trials Registry (UMIN000029970; https://www.umin.ac.jp/ctr/index-j.htm ). The study was conducted from Nov 15, 2017.
format article
author Tomoko Okuyama
Jun Shirakawa
Takashi Nakamura
Takayo Murase
Daisuke Miyashita
Ryota Inoue
Mayu Kyohara
Yu Togashi
Yasuo Terauchi
author_facet Tomoko Okuyama
Jun Shirakawa
Takashi Nakamura
Takayo Murase
Daisuke Miyashita
Ryota Inoue
Mayu Kyohara
Yu Togashi
Yasuo Terauchi
author_sort Tomoko Okuyama
title Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes
title_short Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes
title_full Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes
title_fullStr Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes
title_full_unstemmed Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes
title_sort association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/87d7f33d032f4a0a800350751de49494
work_keys_str_mv AT tomokookuyama associationoftheplasmaxanthineoxidoreductaseactivitywiththemetabolicparametersandvascularcomplicationsinpatientswithtype2diabetes
AT junshirakawa associationoftheplasmaxanthineoxidoreductaseactivitywiththemetabolicparametersandvascularcomplicationsinpatientswithtype2diabetes
AT takashinakamura associationoftheplasmaxanthineoxidoreductaseactivitywiththemetabolicparametersandvascularcomplicationsinpatientswithtype2diabetes
AT takayomurase associationoftheplasmaxanthineoxidoreductaseactivitywiththemetabolicparametersandvascularcomplicationsinpatientswithtype2diabetes
AT daisukemiyashita associationoftheplasmaxanthineoxidoreductaseactivitywiththemetabolicparametersandvascularcomplicationsinpatientswithtype2diabetes
AT ryotainoue associationoftheplasmaxanthineoxidoreductaseactivitywiththemetabolicparametersandvascularcomplicationsinpatientswithtype2diabetes
AT mayukyohara associationoftheplasmaxanthineoxidoreductaseactivitywiththemetabolicparametersandvascularcomplicationsinpatientswithtype2diabetes
AT yutogashi associationoftheplasmaxanthineoxidoreductaseactivitywiththemetabolicparametersandvascularcomplicationsinpatientswithtype2diabetes
AT yasuoterauchi associationoftheplasmaxanthineoxidoreductaseactivitywiththemetabolicparametersandvascularcomplicationsinpatientswithtype2diabetes
_version_ 1718391323104378880